Additionally, ALT+ rates in soft tissue tumors were higher than we had anticipated, at 62%, 58%, and 25% for malignant fibrous histiocytoma, leiomyosarcoma, and liposarcoma, respectively 53-56. This evidence concerns the gene GPT and undifferentiated pleomorphic sarcoma.